The results show that the miR21 promoters with deletion mutants of the second and third AP-1 binding sites, ΔAP1-2 and ΔAP1-3, are less activated by the LCA treatment than that by the original miR21 promoter. Here, JUN is linked to Leber congenital amaurosis.